Jade Biosciences Inc
JBIO
NASDAQ
Biotechnology
$24.71
USD
+0.90 (+3.78%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.51B
Volume 1.5M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - | |
ORIC | Oric Pharmaceuticals Inc | $1.42B | - | - | - | |
INBX | Inhibrx Biosciences Inc | $1.37B | - | +550.0% | - | |
GLUE | Monte Rosa Therapeutics Inc | $1.35B | - | -83.9% | - | |
AKTS | Aktis Oncology Inc | $1.33B | - | +49.9% | - | |
PURR | Hyperliquid Strategies Inc | $1.32B | - | - | - | |
JBIO | Jade Biosciences Inc | $1.32B | - | - | - | |
MNKD | MannKind Corp | $1.29B | - | +30.5% | - | |
NVAX | Novavax Inc | $1.27B | - | -61.6% | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Forte Biosciences Inc
+627.1% Return